News items related to:
-
16 June 2020
• The first report of a treatment that can improve survival among COVID-19 patients on ventilators or oxygen comes from...
-
15 June 2020
• FDA revokes its EUA for chloroquine and hydroxychloroquine, saying “…it is no longer reasonable to believe that oral formulations...
-
14 June 2020
• An editorial warns that OWS is underfunded; an additional US $16 billion is needed to achieve its goal and...
-
11 June 2020
• Over 2 million cases of COVID-19 reported in the US. Source • Brazil announces that it will begin production...
-
10 June 2020
• Over 200,000 cases of COVID-19 reported in Africa. Source • Data from South Africa reports a higher risk of...
-
9 June 2020
WHO launches draft COVID-19 vaccine landscape; 10 candidates have entered human trials, with one in phase IIb/III and 2 are...
-
8 June 2020
Phase I trial of LY-CoV555, an antibody against the COVID-19 spike protein is launched by Eli Lilly and Abcellera. Source
-
5 June 2020
• Three of the Lancet’s hydroxychloroquine paper’s four authors announce the withdrawal of independent peer reviewers, who were unable to...
-
4 June 2020
• Gavi launches the Advance Market Commitment (AMC) for COVID-19 vaccines at the 2020 Global Vaccine Summit, a new financing...
-
3 June 2020
• “Serious scientific questions” about the hydroxychloroquine paper lead Lancet to issue an Expression of Concern; an independent peer review...
-
1 June 2020
• Gilead issues a press release summarizing initial findings from the remdesivir phase III SIMPLE trial in people with moderate...
-
29 May 2020
The EMA issues a press release warning about adverse events from use of chloroquine and hydroxychloroquine for COVID-19. Source